EUVIMEDEUVIMED entdecken
Crossref

L26/P-796 Integrating next-generation sequencing reveals distinct genotype–phenotype patterns in premature ovarian insufficiency

I. Oprova, P. Andreeva, I. Dimova

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von I. Oprova und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does integration of next-generation sequencing with ovarian reserve markers explain the clinical and biochemical heterogeneity of premature ovarian insufficiency? Summary answer NGS enables stratification of women with POI into genetically defined subgroups that display distinct ovarian reserve profiles. What is known already Premature ovarian insufficiency (POI) affects approximately 1% of women under 40 years of age and represents a clinically heterogeneous condition. Despite uniform diagnostic criteria based on gonadotropin elevation and impaired ovarian reserve, disease severity and progression vary considerably. Next-generation sequencing (NGS) has expanded the spectrum of genes associated with POI; however, genetic findings are rarely interpreted in relation to quantitative ovarian reserve markers such as anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH) and antral follicle count (AFC), limiting their clinical applicability. Study design, size, duration This observational study included women diagnosed with POI before the age of 40 years. Selected patients underwent whole-exome sequencing, and genetic findings were analysed alongside routinely assessed ovarian reserve markers during the study period. Participants/materials, setting, methods As part of routine clinical assessment, ovarian reserve markers (FSH, AMH and AFC) were recorded. Whole-exome sequencing was performed, and genetic variants were classified according to pathogenicity. Genetic findings were grouped by biological pathways and analysed in relation to laboratory ovarian reserve profiles to explore genotype–phenotype associations. Main results and the role of chance Next-generation sequencing demonstrated a substantial pathogenic genetic burden, with a mean of 4.6 pathogenic or likely pathogenic variants per patient, predominantly of recessive (mean 2.8) and mitochondrial (mean 0.7) origin, and two variants per patient located in genes directly implicated in premature ovarian insufficiency. Identified variants converged on core biological processes essential for ovarian maintenance, including mitochondrial function, genomic integrity/DNA repair and ciliary/dynein-related pathways. The mitochondrial variant c.370T>C in MT-ND5 was detected at a significantly higher frequency in the study cohort compared with reference European population data (60% vs 9%; p < 0.000005), together with pathogenic variants in genes related to genomic maintenance (FANCM, MSH5, BRCA1) and dynein-related processes (DNAAF3, DNAI1, DNALI1). At the phenotypic level, carriers of pathogenic or likely pathogenic variants exhibited a reduced ovarian reserve profile, characterised by AMH 0.46 ng/ml, FSH 33.31 IU/L and AFC 3 (mean values). Variants of uncertain significance showed a mean burden of 4.8 rare variants per patient, including 1.9 in POI-relevant genes, predominantly affecting pathways involved in hormonal regulation (NANOS1, PROP1, CYP17A1), lipid metabolism (PCSK9, LPL), mitochondrial function (MT-CO3, MT-ND4) and DNA repair (ERCC8, PMS2, POLR3A, FANCM). Women carrying this variant profile exhibited comparatively milder laboratory abnormalities. Limitations, reasons for caution Interpretation is limited by the exploratory design and the evolving classification of rare genetic variants. Wider implications of the findings Integrating NGS results with ovarian reserve markers may improve etiological stratification of POI, support personalised genetic counselling and enhance understanding of variable disease severity. Trial registration number No

Zitieren

APA

Oprova, I., Andreeva, P., & Dimova, I. (2026). L26/P-796 Integrating next-generation sequencing reveals distinct genotype–phenotype patterns in premature ovarian insufficiency. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1123

Vancouver

Oprova I, Andreeva P, Dimova I. L26/P-796 Integrating next-generation sequencing reveals distinct genotype–phenotype patterns in premature ovarian insufficiency. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1123

BibTeX
@article{Oprova2026,
  author = {Oprova, I. and Andreeva, P. and Dimova, I.},
  title = {L26/P-796 Integrating next-generation sequencing reveals distinct genotype–phenotype patterns in premature ovarian insufficiency},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1123}
}
Kostenlos starten →